ACUTA CAPITAL PARTNERS, LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001582844
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2024 · 33 positions · Total reported value $118.74M · Top-10 concentration 65.3% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 52.9% · 11 new · 7 cut · 0 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -16.4% · vs SPY -18.5% · Prev Value $143.49M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -8.3% · vs SPY -10.5% · Latest Value $126.75M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q2 2024 13F filing, ACUTA CAPITAL PARTNERS, LLC disclosed 33 equity positions with a combined reported value of $118.74M. The filing implies a focused portfolio: its ten largest positions account for 65.3% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2024 were OCUL ($18.95M), ELVN ($9.29M), PCVX ($8.34M). By sector, the heaviest allocations are Health Care 83.5%, Other 16.5%. Versus the prior quarter, allocation shifted toward Health Care (+7.2pp) and away from Other (-7.2pp).
Versus the prior quarter, ACUTA CAPITAL PARTNERS, LLC opened 11 new positions, trimmed 7 and fully exited 0, a turnover rate of 52.9% of positions. The portfolio's overlap with the prior quarter was 57% of names.
The largest new positions opened in Q2 2024 were CRBP ($2.92M), HLXB ($1.82M), ARGX ($1.72M).
Of the 8 positions fully exited versus the prior quarter, the largest were APLT ($5.39M), IRON ($4.78M), CLDX ($4.57M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2024)
- CRBP CORBUS PHARMACEUTICALS HLDGS · $2.92M
- HLXB HELIX ACQUISITION CORP II · $1.82M
- ARGX ARGENX SE · $1.72M
- TRVI TREVI THERAPEUTICS INC · $774.80K
- CELC CELCUITY INC · $737.10K
- PLRX PLIANT THERAPEUTICS INC · $496.65K
- RAPP RAPPORT THERAPEUTICS INC · $465.20K
- NAMS NEWAMSTERDAM PHARMA COMPANY · $432.23K
Fully Exited (vs previous quarter)
- APLT APPLIED THERAPEUTICS INC · prev qtr: $5.39M
- IRON DISC MEDICINE INC · prev qtr: $4.78M
- CLDX CELLDEX THERAPEUTICS INC NEW · prev qtr: $4.57M
- HLVX HILLEVAX INC · prev qtr: $4.17M
- IMVT IMMUNOVANT INC · prev qtr: $2.98M
- VSTM VERASTEM INC · prev qtr: $2.44M
- LYRA LYRA THERAPEUTICS INC · prev qtr: $1.08M
- RARE ULTRAGENYX PHARMACEUTICAL IN · prev qtr: $933.80K
Insider Transactions (Form 4)
Latest ACUTA CAPITAL PARTNERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Acuta Capital Partners, based in Redwood City, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 23 positions worth $143.49M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: REDWOOD CITY, CA, United States
- SEC registration: 801-136966 (status: Approved), registered 2026-09-09
- Regulatory AUM (Form ADV): $172.53M as of 2026-06-30
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 2 private funds, of which 2 hedge funds
- Website: acutacapital.com
Portfolio Structure
- 23 positions · $143.49M reported value (Q2 2026)
- Top 10 holdings = 73.7% of reported value
- Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 19.3%
- Average position size: $6.24M
Sector Tilt
- Health Care 100.0%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 4 new, 7 added, 6 reduced, 7 exited
- 6 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
2.77M | $18.95M | 15.96% | Add | |
| 2 |
|
397.70K | $9.29M | 7.83% | Hold | |
| 3 |
|
110.40K | $8.34M | 7.02% | Add | |
| 4 |
|
212.50K | $7.50M | 6.32% | Add | |
| 5 |
|
164.43K | $6.80M | 5.73% | Add | |
| 6 |
|
135.14K | $6.05M | 5.10% | Add | |
| 7 |
|
250.37K | $5.39M | 4.54% | Reduce | |
| 8 |
|
2.33M | $5.22M | 4.40% | Reduce | |
| 9 |
|
133.00K | $5.16M | 4.35% | Reduce | |
| 10 |
|
72.10K | $4.83M | 4.07% | Add | |
| 11 |
|
27.50K | $4.34M | 3.66% | Reduce | |
| 12 |
|
269.61K | $3.47M | 2.92% | Add | |
| 13 |
|
78.70K | $3.39M | 2.86% | Add | |
| 14 |
|
163.00K | $3.36M | 2.83% | Add | |
| 15 |
|
1.66M | $3.34M | 2.81% | Reduce | |
| 16 |
|
64.50K | $2.92M | 2.46% | New | |
| 17 |
|
1.85M | $2.70M | 2.27% | Hold | |
| 18 |
|
199.43K | $2.59M | 2.19% | Hold | |
| 19 |
|
369.28K | $2.51M | 2.12% | Reduce | |
| 20 |
|
677.00K | $2.44M | 2.05% | Add | |
| 21 |
|
42.20K | $2.33M | 1.96% | Add | |
| 22 |
|
177.84K | $1.82M | 1.53% | New | |
| 23 |
|
4.00K | $1.72M | 1.45% | New | |
| 24 |
|
260.00K | $774.80K | 0.65% | New | |
| 25 |
|
45.00K | $737.10K | 0.62% | New | |
| 26 |
|
96.00K | $678.72K | 0.57% | Reduce | |
| 27 |
|
46.20K | $496.65K | 0.42% | New | |
| 28 |
|
20.00K | $465.20K | 0.39% | New | |
| 29 |
|
22.50K | $432.23K | 0.36% | New | |
| 30 |
|
195.00K | $382.20K | 0.32% | Reduce | |
| 31 |
|
70.50K | $176.25K | 0.15% | Reduce | |
| 32 |
|
250 | $100.75K | 0.09% | New | |
| 33 |
|
90.83K | $14.53K | 0.01% | Hold | |
FAQ
What did ACUTA CAPITAL PARTNERS, LLC buy in 2024-Q2?
In its 2024-Q2 13F filing, ACUTA CAPITAL PARTNERS, LLC reported 33 equity positions worth $118.74M in aggregate; its largest disclosed positions were OCUL ($18.95M), ELVN ($9.29M), PCVX ($8.34M).
How large is ACUTA CAPITAL PARTNERS, LLC's portfolio?
ACUTA CAPITAL PARTNERS, LLC reported $118.74M of long equity holdings across 33 positions as of 2024-Q2. Top-10 holdings account for 65.3% of reported value.
What is ACUTA CAPITAL PARTNERS, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.